References
- Skegg K, Corwin A A, Skegg D CG. How often is multiple sclerosis mistaken for a psychiatric disorder. Psychol Med 1988; 49: 364–6
- Laasonen-Balk T, Solismaa M, Koponen H J. Adolescent conduct disorder, depression, and central nervous system demyelinization in magnetic resonance imaging. A report with two cases. Nord J Psychiatry 1996; 50: 419–21
- Poser C M, Paty D W, Scheinberg L, McDonald I, Davis F A, Ebers G C, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227–31
- Liedholm L J, Gard A, Binzer M, Fredikson S. Multipel skleros — det finns imitatörer!. Nord Med 1995; 110: 184–7
- Stenaeer E, Knudsen L, Jensen K. Psvchiatric and cognitive aspects of muitiple sclerosis. Sem Neurol 1990; 10: 254–61
- Stenager E, Knudsen L, Jensen K. Dissemineret sklerose: organisk grundlag for sindslidelse og kognitiv dysfunktion. Nord Med 1991; 106: 43–4
- Stenager E, Knudsen L, Jensen K. Multiple sclerosis: results of screening by the Token test in a representative sample. Ital J Neurol Sci 1992; 13: 798–99
- Stenager E N, Stenager E, Koch-Henriksen N, Brønnum-Hansen H, Hyllested K, Jensen K, et al. Suicide and multiple sclerosis: an epidemiological study. J Neurol Neurosurg Psychiatr 1992; 55: 542–5
- Stenager E N, Stenager E. Suicide and patients with neurological diseases. Methodological problems. Arch Neurol 1992; 49: 1296–303
- Stenager E N, Stenager E. Disease, pain, and suicidal behaviour. Haworth Press, New York, In press
- Stenager E, Jensen K. Multiple sclerosis: correlation of psychiatric admission to onset of initial symptoms. Acta Neurol Scand 1988; 77: 414–7
- Stenager E, Stenager E N, Knudsen L, Jensen K. Psykosociale aspekter ved dissemineret sklerose. Ugeskr Laeger 1995; 157: 1838–41
- Stenager E, Knudsen L, Jensen K. Multiple sclerosis: the impact of physical impairment and cognitive dysfunction on social and sparetime activities. Psychother Psychosom 1991; 56: 123–8
- Skegg K. Multiple sclerosis presenting as a pure psychiatric disorder. Psychol Med 1993; 23: 909–14
- Johannsen L GK, Stenager E, Jensen K. Clinically unexpected multiple sclerosis in patients with mental disorders. A series of 7301 psychiatric autopsies. Acta Neurol Belg 1996; 96: 62–5
- Ratey J, Sovner R, Mikkelsen E, Chmielinski H. Buspirone therapy for maladaptive behavior and anxiety in developmentally disabled persons. J Clin Psychiatry 1989; 50: 382–4
- Ratey J, Sovner R, Parks A, Rogentine K. Buspirone treatment of aggression and anxiety in mentally retarded patients: a multiple-baseline placebo lead-in study. J Clin Psychiatry 1991; 52: 159–62
- Ricketts R W, Goza A B, Ellis C R, Singh Y N, Chambers S, Singh N N, et al. Clinical effects of buspirone on intractable self-injury in adults with mental retardation. J Am Acad Child Adolesc Psychiatry 1994; 33: 270–6
- Tuinier S, Verhoeven W. Pharmacological advances in mental retardation: a need for reconceptualisation. Curr Opin Psychiatry 1994; 7: 380–6